Journal
JOURNAL OF CONTROLLED RELEASE
Volume 329, Issue -, Pages 96-120Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2020.11.047
Keywords
Combination therapy; Chemo therapy; Repurposed drug; Phytochemicals
Funding
- Chinese Scholarship Council
Ask authors/readers for more resources
Combination therapy has long been used to improve anti-tumor efficacy and address multidrug resistance in cancer treatment. Repurposed non-chemo drugs and dietary phytochemicals are promising alternatives that offer a safe and cost-effective strategy for conventional anti-tumor therapeutics.
Combination therapy has long been applied to enhance therapeutic effect and deal with the occurrence of multidrug resistance in cancer treatment. However, the overlapping toxicity of multiple anticancer drugs to healthy tissues and increasing financial burden on patients emerged as major concerns. As promising alternatives to chemo agents, repurposed non-chemo drugs and dietary phytochemicals have been investigated as adjuvants to conventional anti-tumor therapeutics, offering a safe and economic strategy for combination therapy. In this review, we aim to highlight the advances in research about combination therapy using conventional therapeutics and repurposed drugs or phytochemicals for an enhanced anti-tumor efficacy, along with the mechanisms involved in the synergism. Beyond these, we outlined the potential challenges and solutions for clinical translation of the proposed combination therapy, providing a safe and affordable strategy to improve the reach of cancer therapy to low income regions with such new tricks of old drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available